Literature DB >> 2659536

Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release.

A Ferrante1.   

Abstract

The capacity of human tumor necrosis factor alpha (TNF-alpha) to modulate the killing of the opportunistic pathogens Torulopsis glabrata and Candida albicans by human neutrophils was studied. TNF-alpha significantly enhanced neutrophil fungicidal activity in a concentration-dependent manner and was evident in a range of neutrophil-fungus ratios. Enhanced killing of T. glabrata required much lower TNF-alpha concentrations than were required for enhancement of killing of C. albicans. Maximal enhancement of killing occurred with 20 and 100 U of TNF-alpha per 5 x 10(6) neutrophils for T. glabrata and C. albicans, respectively. The fungal killing kinetics demonstrated that TNF-alpha augmentation of fungicidal activity was evident within 1 h and persisted for an incubation period of at least 22 h. Preincubation of neutrophils with TNF-alpha was essential for the enhancement of killing. Maximal stimulation of killing was observed within 1 h of preincubation with TNF-alpha, and poor stimulation of killing was observed when TNF-alpha was added at time zero. Associated with the increase in fungicidal activity was an increased production of superoxide and an enhanced degranulation of enzymes and other proteins from azurophilic and specific granules in response to the fungi. The results demonstrate that TNF-alpha augments the neutrophil oxidative respiratory burst and the degranulation induced by opsonized fungi and that it increases the neutrophil fungicidal activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659536      PMCID: PMC313849          DOI: 10.1128/iai.57.7.2115-2122.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Alternative pathway of complement activation by Candida albicans.

Authors:  Y H Thong; A Ferrante
Journal:  Aust N Z J Med       Date:  1978-12

2.  Separation of mononuclear and polymorphonuclear leucocytes from human blood by the one-step Hypaque-Ficoll method is dependent on blood column height.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

3.  Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator.

Authors:  R H Weisbart; D W Golde; S C Clark; G G Wong; J C Gasson
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

4.  Stimulation of human neutrophil degranulation by mefloquine.

Authors:  E J Bates; A Ferrante
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

5.  Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.

Authors:  J R Gamble; J M Harlan; S J Klebanoff; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Phagocytic killing of Candida albicans by different murine effector cells.

Authors:  M Baccarini; E Blasi; P Puccetti; F Bistoni
Journal:  Sabouraudia       Date:  1983-12

7.  Conditioned medium from stimulated mononuclear leukocytes augments human neutrophil-mediated killing of a virulent Acanthamoeba sp.

Authors:  A Ferrante; T J Abell
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

8.  Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

Authors:  M R Shalaby; B B Aggarwal; E Rinderknecht; L P Svedersky; B S Finkle; M A Palladino
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

9.  Candidacidal activity of myeloperoxidase: mechanisms of inhibitory influence of soluble cell wall mannan.

Authors:  C D Wright; J U Bowie; G R Gray; R D Nelson
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

10.  Specific binding of leukocyte inhibitory factor to neutrophil plasma membranes.

Authors:  M S Klempner; R E Rocklin
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

View more
  48 in total

1.  Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor.

Authors:  D Chatterjee; A D Roberts; K Lowell; P J Brennan; I M Orme
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.

Authors:  J Brieland; D Essig; C Jackson; D Frank; D Loebenberg; F Menzel; B Arnold; B DiDomenico; R Hare
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Effect of 22-32 carbon n-3 polyunsaturated fatty acids on superoxide production in human neutrophils: synergism of docosahexaenoic acid with f-met-leu-phe and phorbol ester.

Authors:  A Poulos; B S Robinson; A Ferrante; D P Harvey; S J Hardy; A W Murray
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

4.  Granulocyte-macrophage colony-stimulating factor augments neutrophil killing of Torulopsis glabrata and stimulates neutrophil respiratory burst and degranulation.

Authors:  I C Kowanko; A Ferrante; D P Harvey; K L Carman
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

5.  Chromatin-mediated Candida albicans virulence.

Authors:  Jessica Lopes da Rosa; Paul D Kaufman
Journal:  Biochim Biophys Acta       Date:  2011-08-24

Review 6.  IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans.

Authors:  Heather R Conti; Sarah L Gaffen
Journal:  J Immunol       Date:  2015-08-01       Impact factor: 5.422

7.  Contrasting influence of peplomycin and azelastine hydrochloride (Azeptin) on reactive oxygen generation in polymorphonuclear leukocytes, cytokine generation in lymphocytes, and collagen synthesis in fibroblasts.

Authors:  E Ueta; T Osaki; K Yoneda; T Yamamoto
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus.

Authors:  E Roilides; A Dimitriadou-Georgiadou; T Sein; I Kadiltsoglou; T J Walsh
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro.

Authors:  R D Diamond; C A Lyman; D R Wysong
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

10.  Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans.

Authors:  E Blasi; L Pitzurra; M Puliti; L Lanfrancone; F Bistoni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.